|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1601 to 1700 out of 2334 for Erbb2

0.04s

Categories

Hits by Pathway

Hits by Strain

Hits by Category

Type Details Score
Protein
Organism: Mus musculus/domesticus
Length: 672  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 733  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 1210  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 193  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 537  
Fragment?: false
Protein
Organism: Mus musculus/domesticus
Length: 424  
Fragment?: false
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus caroli
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: mouse, laboratory
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus pahari
Protein Coding Gene
Type: protein_coding_gene
Organism: Mus spretus
GXD Expression      
Probe: MGI:6444277
Assay Type: RT-PCR
Annotation Date: 2020-07-28
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1716828
Stage: TS28
Assay Id: MGI:6445580
Age: postnatal week 5
Specimen Label: wild type control
Detected: true
Specimen Num: 1
GXD Expression      
Probe: MGI:6444277
Assay Type: RT-PCR
Annotation Date: 2020-07-28
Strength: Present
Sex: Not Specified
Emaps: EMAPS:1716828
Stage: TS28
Assay Id: MGI:6445580
Age: postnatal week 5
Specimen Label: miR-183C
Detected: true
Specimen Num: 2
Publication
First Author: Zhang C
Year: 2010
Journal: Cancer Res
Title: Tip30 deletion in MMTV-Neu mice leads to enhanced EGFR signaling and development of estrogen receptor-positive and progesterone receptor-negative mammary tumors.
Volume: 70
Issue: 24
Pages: 10224-33
Publication
First Author: Taylor NA
Year: 2017
Journal: J Clin Invest
Title: Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
Volume: 127
Issue: 9
Pages: 3472-3483
Publication
First Author: Chen EP
Year: 2014
Journal: Carcinogenesis
Title: Myeloid Cell COX-2 deletion reduces mammary tumor growth through enhanced cytotoxic T-lymphocyte function.
Volume: 35
Issue: 8
Pages: 1788-97
Publication
First Author: Zhang X
Year: 2010
Journal: Cancer Res
Title: Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.
Volume: 70
Issue: 18
Pages: 7176-86
Publication
First Author: Pathania R
Year: 2016
Journal: Cancer Res
Title: Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.
Volume: 76
Issue: 11
Pages: 3224-35
Publication
First Author: Ramirez NE
Year: 2011
Journal: J Clin Invest
Title: The α₂β₁ integrin is a metastasis suppressor in mouse models and human cancer.
Volume: 121
Issue: 1
Pages: 226-37
Publication
First Author: Yu Q
Year: 2006
Journal: Cancer Cell
Title: Requirement for CDK4 kinase function in breast cancer.
Volume: 9
Issue: 1
Pages: 23-32
Publication
First Author: Howe LR
Year: 2005
Journal: Cancer Res
Title: HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice.
Volume: 65
Issue: 21
Pages: 10113-9
Publication
First Author: Miranda-Carboni GA
Year: 2008
Journal: Genes Dev
Title: A functional link between Wnt signaling and SKP2-independent p27 turnover in mammary tumors.
Volume: 22
Issue: 22
Pages: 3121-34
Publication
First Author: Rowson-Hodel AR
Year: 2018
Journal: Oncogene
Title: Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer.
Volume: 37
Issue: 2
Pages: 197-207
Publication
First Author: Ursini-Siegel J
Year: 2010
Journal: Cancer Res
Title: Receptor tyrosine kinase signaling favors a protumorigenic state in breast cancer cells by inhibiting the adaptive immune response.
Volume: 70
Issue: 20
Pages: 7776-87
Publication
First Author: Ciocca DR
Year: 2012
Journal: Histochem Cell Biol
Title: Absence of caveolin-1 alters heat shock protein expression in spontaneous mammary tumors driven by Her-2/neu expression.
Volume: 137
Issue: 2
Pages: 187-94
Publication
First Author: Sloan EK
Year: 2009
Journal: Am J Pathol
Title: Stromal cell expression of caveolin-1 predicts outcome in breast cancer.
Volume: 174
Issue: 6
Pages: 2035-43
Publication  
First Author: Ahn R
Year: 2017
Journal: Nat Commun
Title: The Shc1 adaptor simultaneously balances Stat1 and Stat3 activity to promote breast cancer immune suppression.
Volume: 8
Pages: 14638
Publication  
First Author: Benezra R
Year: 2005
Journal: Cold Spring Harb Symp Quant Biol
Title: Induction of complete regressions of oncogene-induced breast tumors in mice.
Volume: 70
Pages: 375-81
Publication
First Author: Wan L
Year: 2014
Journal: Cancer Cell
Title: MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Volume: 26
Issue: 1
Pages: 92-105
Publication
First Author: Fleming NI
Year: 2009
Journal: Cancer Res
Title: Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ.
Volume: 69
Issue: 18
Pages: 7473-9
Publication
First Author: Grosset AA
Year: 2016
Journal: PLoS One
Title: Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer.
Volume: 11
Issue: 11
Pages: e0166731
Publication
First Author: Yori JL
Year: 2014
Journal: Cancer Res
Title: Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.
Volume: 74
Issue: 17
Pages: 4762-71
Publication
First Author: Sheng G
Year: 2021
Journal: PLoS One
Title: Reduction of fibrosis and immune suppressive cells in ErbB2-dependent tumorigenesis by an LXR agonist.
Volume: 16
Issue: 3
Pages: e0248996
Publication
First Author: Brodie SG
Year: 2001
Journal: Oncogene
Title: Inactivation of p53 tumor suppressor gene acts synergistically with c-neu oncogene in salivary gland tumorigenesis.
Volume: 20
Issue: 12
Pages: 1445-54
Publication
First Author: Bentires-Alj M
Year: 2007
Journal: Cancer Res
Title: Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer.
Volume: 67
Issue: 6
Pages: 2420-4
Publication
First Author: Sangrar W
Year: 2015
Journal: Oncogene
Title: Amplified Ras-MAPK signal states correlate with accelerated EGFR internalization, cytostasis and delayed HER2 tumor onset in Fer-deficient model systems.
Volume: 34
Issue: 31
Pages: 4109-17
Publication  
First Author: Oh S
Year: 2018
Journal: Cell Signal
Title: Egr-1 is required for neu/HER2-induced mammary tumors.
Volume: 45
Pages: 102-109
Publication  
First Author: Wu H
Year: 2023
Journal: Int J Mol Sci
Title: Dietary Supplementation of Inulin Contributes to the Prevention of Estrogen Receptor-Negative Mammary Cancer by Alteration of Gut Microbial Communities and Epigenetic Regulations.
Volume: 24
Issue: 10
Publication
First Author: Chen X
Year: 2016
Journal: PLoS One
Title: CCL2/CCR2 Regulates the Tumor Microenvironment in HER-2/neu-Driven Mammary Carcinomas in Mice.
Volume: 11
Issue: 11
Pages: e0165595
Publication
First Author: Dong Y
Year: 2014
Journal: Cell Res
Title: Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Volume: 24
Issue: 11
Pages: 1354-66
Publication
First Author: Petrova SC
Year: 2020
Journal: Oncotarget
Title: Regulation of breast cancer oncogenesis by the cell of origin's differentiation state.
Volume: 11
Issue: 43
Pages: 3832-3848
Publication
First Author: Chen DY
Year: 2012
Journal: Cancer Res
Title: A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.
Volume: 72
Issue: 3
Pages: 736-46
Publication
First Author: Gabai VL
Year: 2012
Journal: Mol Cell Biol
Title: Heat shock transcription factor Hsf1 is involved in tumor progression via regulation of hypoxia-inducible factor 1 and RNA-binding protein HuR.
Volume: 32
Issue: 5
Pages: 929-40
Publication
First Author: Sizemore GM
Year: 2017
Journal: Oncogene
Title: Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1.
Volume: 36
Issue: 16
Pages: 2297-2308
Publication
First Author: Triulzi C
Year: 2010
Journal: Cancer Res
Title: Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
Volume: 70
Issue: 19
Pages: 7431-41
Publication
First Author: Landis MD
Year: 2006
Journal: Oncogene
Title: Sustained trophism of the mammary gland is sufficient to accelerate and synchronize development of ErbB2/Neu-induced tumors.
Volume: 25
Issue: 23
Pages: 3325-34
Publication
First Author: Yan L
Year: 2011
Journal: PLoS One
Title: Activation of the canonical Wnt/β-catenin pathway in ATF3-induced mammary tumors.
Volume: 6
Issue: 1
Pages: e16515
Publication
First Author: Chang H
Year: 2012
Journal: Dev Biol
Title: Mammary epithelial-restricted expression of activated c-src rescues the block to mammary gland morphogenesis due to the deletion of the C-terminus of Patched-1.
Volume: 370
Issue: 2
Pages: 187-97
Publication
First Author: Borcherding N
Year: 2015
Journal: Cancer Res
Title: Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.
Volume: 75
Issue: 10
Pages: 1972-82
Strain
Attribute String: transgenic, mutant strain
Publication
First Author: Park JM
Year: 2015
Journal: Oncogene
Title: The role of Tcfap2c in tumorigenesis and cancer growth in an activated Neu model of mammary carcinogenesis.
Volume: 34
Issue: 50
Pages: 6105-14
Publication
First Author: Shimizu Y
Year: 2018
Journal: Carcinogenesis
Title: Genetic deletion of sphingosine kinase 1 suppresses mouse breast tumor development in an HER2 transgenic model.
Volume: 39
Issue: 1
Pages: 47-55
Publication
First Author: Erdman SE
Year: 2010
Journal: Int J Cancer
Title: Unifying roles for regulatory T cells and inflammation in cancer.
Volume: 126
Issue: 7
Pages: 1651-65
Publication
First Author: Li M
Year: 2018
Journal: Circulation
Title: Phosphoinositide 3-Kinase Gamma Inhibition Protects From Anthracycline Cardiotoxicity and Reduces Tumor Growth.
Volume: 138
Issue: 7
Pages: 696-711
Publication
First Author: Thompson JA
Year: 1997
Journal: Int J Cancer
Title: Expression of transgenic carcinoembryonic antigen (CEA) in tumor-prone mice: an animal model for CEA-directed tumor immunotherapy.
Volume: 72
Issue: 1
Pages: 197-202
Publication
First Author: Deng Q
Year: 2019
Journal: Nat Commun
Title: Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.
Volume: 10
Issue: 1
Pages: 5061
Publication
First Author: Quaglino E
Year: 2004
Journal: Cancer Res
Title: Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice.
Volume: 64
Issue: 8
Pages: 2858-64
Publication
First Author: Vallerand D
Year: 2016
Journal: PLoS One
Title: Characterization of Breast Cancer Preclinical Models Reveals a Specific Pattern of Macrophage Polarization.
Volume: 11
Issue: 7
Pages: e0157670
Publication
First Author: Zinser GM
Year: 2004
Journal: Carcinogenesis
Title: Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Volume: 25
Issue: 12
Pages: 2361-72
Publication
First Author: Ross C
Year: 2020
Journal: Mol Cancer Res
Title: Metastasis-Specific Gene Expression in Autochthonous and Allograft Mouse Mammary Tumor Models: Stratification and Identification of Targetable Signatures.
Volume: 18
Issue: 9
Pages: 1278-1289
Publication
First Author: Huang S
Year: 2005
Journal: Genome Biol
Title: Changes in gene expression during the development of mammary tumors in MMTV-Wnt-1 transgenic mice.
Volume: 6
Issue: 10
Pages: R84
Publication
First Author: Jones CE
Year: 2019
Journal: Neoplasia
Title: Stromal PTEN Regulates Extracellular Matrix Organization in the Mammary Gland.
Volume: 21
Issue: 1
Pages: 132-145
Publication
First Author: Chen M
Year: 2022
Journal: Carcinogenesis
Title: Maternal soybean genistein on prevention of later-life breast cancer through inherited epigenetic regulations.
Volume: 43
Issue: 3
Pages: 190-202
Publication
First Author: Chanmee T
Year: 2014
Journal: J Biol Chem
Title: Excessive hyaluronan production promotes acquisition of cancer stem cell signatures through the coordinated regulation of Twist and the transforming growth factor β (TGF-β)-Snail signaling axis.
Volume: 289
Issue: 38
Pages: 26038-26056
Publication
First Author: Rosner A
Year: 2002
Journal: Am J Pathol
Title: Pathway pathology: histological differences between ErbB/Ras and Wnt pathway transgenic mammary tumors.
Volume: 161
Issue: 3
Pages: 1087-97
Publication
First Author: Prokakis E
Year: 2021
Journal: Oncogene
Title: USP22 promotes HER2-driven mammary carcinoma aggressiveness by suppressing the unfolded protein response.
Volume: 40
Issue: 23
Pages: 4004-4018
Publication
First Author: Davis VL
Year: 2012
Journal: Horm Cancer
Title: Inhibition of Neu-induced mammary carcinogenesis in transgenic mice expressing ERΔ3, a dominant negative estrogen receptor α variant.
Volume: 3
Issue: 5-6
Pages: 227-39
Publication
First Author: Wang Z
Year: 2017
Journal: Dev Cell
Title: Binding of PLD2-Generated Phosphatidic Acid to KIF5B Promotes MT1-MMP Surface Trafficking and Lung Metastasis of Mouse Breast Cancer Cells.
Volume: 43
Issue: 2
Pages: 186-197.e7
Publication
First Author: Joshi S
Year: 2017
Journal: Am J Cancer Res
Title: 14-3-3ζ loss impedes oncogene-induced mammary tumorigenesis and metastasis by attenuating oncogenic signaling.
Volume: 7
Issue: 8
Pages: 1654-1664
Publication
First Author: Tardáguila M
Year: 2013
Journal: Cancer Res
Title: CX3CL1 promotes breast cancer via transactivation of the EGF pathway.
Volume: 73
Issue: 14
Pages: 4461-73
Publication
First Author: Wan R
Year: 2012
Journal: Int J Oncol
Title: Haploinsufficiency of the Nijmegen breakage syndrome 1 gene increases mammary tumor latency and metastasis.
Volume: 41
Issue: 1
Pages: 345-52
Publication
First Author: Parsons MJ
Year: 2013
Journal: Cell Death Differ
Title: Genetic deletion of caspase-2 accelerates MMTV/c-neu-driven mammary carcinogenesis in mice.
Volume: 20
Issue: 9
Pages: 1174-82
Publication
First Author: Schug TT
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARbeta/delta to RAR.
Volume: 105
Issue: 21
Pages: 7546-51
Publication
First Author: Cao J
Year: 2014
Journal: Cell Rep
Title: Histone demethylase RBP2 is critical for breast cancer progression and metastasis.
Volume: 6
Issue: 5
Pages: 868-77
Publication
First Author: Alexandrova EM
Year: 2017
Journal: Cell Death Dis
Title: p53 loss-of-heterozygosity is a necessary prerequisite for mutant p53 stabilization and gain-of-function in vivo.
Volume: 8
Issue: 3
Pages: e2661
Strain
Attribute String: coisogenic, mutant strain, transgenic
Strain
Attribute String: coisogenic, mutant strain, transgenic
Publication
First Author: Pedersen K
Year: 2009
Journal: Mol Cell Biol
Title: A naturally occurring HER2 carboxy-terminal fragment promotes mammary tumor growth and metastasis.
Volume: 29
Issue: 12
Pages: 3319-31
Publication
First Author: MacLennan MB
Year: 2013
Journal: J Nutr Biochem
Title: Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids.
Volume: 24
Issue: 1
Pages: 388-95
Publication
First Author: Hutchinson JN
Year: 2004
Journal: Cancer Res
Title: Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion.
Volume: 64
Issue: 9
Pages: 3171-8
Publication
First Author: Itah Z
Year: 2023
Journal: Proc Natl Acad Sci U S A
Title: HER2-driven breast cancer suppression by the JNK signaling pathway.
Volume: 120
Issue: 4
Pages: e2218373120
Genotype
Symbol: Tg(MMTV-ERBB3)1Slg/? Tg(MMTVneu)202Mul/?
Background: involves: FVB
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Etv4/Etv4 Tg(MMTVneu)202Mul/Tg(MMTVneu)202Mul
Background: involves: FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2 Tg(Ckmm-cre)5Khn/?
Background: involves: 129S1/Sv * 129X1/SvJ * BALB/c * FVB
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Ccnd1/Ccnd1 Tg(MMTV-Erbb2)NK1Mul/?
Background: involves: 129S4/SvJae * C57BL/6 * FVB/N
Zygosity: cx
Has Mutant Allele: true
Genotype
Symbol: Erbb2/Erbb2 Myl2/Myl2<+>
Background: involves: 129P2/OlaHsd * 129S4/SvJae
Zygosity: cn
Has Mutant Allele: true